Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes patchy hair loss and has no cure, but treatments like corticosteroids and minoxidil can help.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Malassezia infection may cause refractory acne, and antifungal treatments can help.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The document concludes that choosing the right forehead and brow lifting technique based on individual patient characteristics is crucial to prevent complications and achieve desired results.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The conclusion is that a team of skin doctors and psychiatrists is needed to better treat patients with mind-skin disorders.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Cetuximab can cause excessive eyelash growth.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

UV rays can cause a type of hair loss known as telogen alopecia.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.